Serotonin1A-receptor agonism attenuates the cocaine-induced increase in serotonin levels in the hippocampus and nucleus accumbens but potentiates hyperlocomotion: An in vivo microdialysis study

Neuropharmacology

Volumn 44, Issue 5, 2003, Pages 592-603

  Muller C P ^a   Carey, R J ^b   Salloum, J B ^a   Huston, J P ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

Author keywords

Behaviour; Hippocampus; Microdialysis; Nucleus accumbens; Serotonin

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; COCAINE; SEROTONIN; SODIUM CHLORIDE; SEROTONIN 1 RECEPTOR; SEROTONIN AGONIST; SEROTONIN RECEPTOR;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; IN VIVO STUDY; LOCOMOTION; MALE; MICRODIALYSIS; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; SEROTONIN BLOOD LEVEL; ANIMAL; DRUG POTENTIATION; HIPPOCAMPUS; METABOLISM; METHODOLOGY; PHYSIOLOGY; WISTAR RAT;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ANIMALS; COCAINE; DRUG SYNERGISM; HIPPOCAMPUS; LOCOMOTION; MALE; MICRODIALYSIS; NUCLEUS ACCUMBENS; RATS; RATS, WISTAR; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT1; SEROTONIN; SEROTONIN AGONISTS;

EID: 0037382379     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(03)00046-7     Document Type: Article

References (66)

1. Arvidsson L.E., Hacksell U., Nilsson J.L.G., Hjorth S., Carlsson A. 8-Hydroxy-2-(di-n-propylamino)tetralin, a new centrally acting 5-hydroxytryptamine receptor agonist. Journal of Medical Chemistry. 24:1981;921-923.
2. Bardgett M.E., Henry J.D. Locomotor activity and accumbens Fos expression driven by ventral hippocampal stimulation require D1 and D2 receptors. Neuroscience. 94:1999;59-70.
3. Blier P., Serrano A., Scatton B. Differential responsiveness of the rat dorsal and median raphe 5-HT systems to 5-HT1 receptor agonists and p-chloroamphetamine. Synapse. 5:1990;120-133.
4. Boix F., Pfister M., Huston J.P., Schwarting R.K. Substance P decreases extracellular concentrations of acetylcholine in neostriatum and nucleus accumbens in vivo: possible relevance for the central processing of reward and aversion. Behavioural Brain Research. 63:1994;213-219.
5. Boix F., Sandor P., Nogueira P.J., Huston J.P., Schwarting R.K. Relationship between dopamine release in nucleus accumbens and place preference induced by substance P injected into the nucleus basalis magnocellularis region. Neuroscience. 64:1995;1045-1055.
6. Bonvento G., Scatton B., Claustre Y., Rouquier L. Effect of local injection of 8-OH-DPAT into the dorsal or median raphe nuclei on extracellular levels of serotonin in serotonergic projection areas in the rat brain. Neuroscience Letters. 137:1992;101-104.
7. Carey R., Damianopoulos E., DePalma G. The 5-HT(1A) antagonist WAY 100635 can block the low-dose locomotor stimulant effects of cocaine. Brain Research. 862:2000;242-246.
8. Carey R.J., DePalma G., Damianopoulos E. Cocaine and serotonin: a role for the 5-HT(1A) receptor site in the mediation of cocaine stimulant effects. Behavioural Brain Research. 126:2001;127-133.
9. 1A agonist/antagonist modification of cocaine stimulant effects: implications for cocaine mechanisms. Behavioural Brain Research. 132:2002;37-46.
10. 1A agonists on stress-induced deficit in open field locomotor activity of rats: evidence that this model identifies anxiolytic-like activity. Neuropharmacology. 28:(5):1989;471-476.
11. Casanovas J.M., Artigas F. Differential effects of ipsapirone on 5-hydroxytryptamine release in the dorsal and median raphe neuronal pathways. Journal of Neurochemistry. 67:1996;1945-1952.
12. 1A agonists alnespirone (S-20499) and 8-OH-DPAT on extracellular 5-hydroxytryptamine in different regions of rat brain. British Journal of Pharmacology. 122:1997;733-741.
13. Costall B., Kelly M.E., Naylor R.J., Onaivi E.S. The actions of nicotine and cocaine in a mouse model of anxiety. Pharmacology Biochemistry and Behavior. 33:1989;197-203.
14. Cumming P., Brown E., Damsma G., Fibiger H. Formation and clearance of interstitial metabolites of dopamine and serotonin in the rat striatum: an in vivo microdialysis study. Journal of Neurochemistry. 59:1992;1905-1914.
15. De La Garza R.D., Cunningham K.A. The effects of the 5-hydroxytryptamine(1A) agonist 8-hydroxy-2-(di-n-propylamino)tetralin on spontaneous activity, cocaine-induced hyperactivity and behavioural sensitization: a microanalysis of locomotor activity. Journal of Pharmacology and Experimental Therapeutics. 292:2000;610-617.
16. Dourish C.T., Hutson P.H., Curzon G. Low doses of the putative serotonin agonist 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) elicit feeding in the rat. Psychopharmacology. 86:1985;197-204.
17. Dringenberg H.C., De Souza Silva M.A., Roßmüller J., Huston J.P., Schwarting R.K.W. Histamine H1 receptor antagonists produce increases in extracellular acetylcholine in rat frontal cortex and hippocampus. Journal of Neurochemistry. 10:1998;1750-1758.
18. Evenden J.L., Ängeby-Möller K. Effects of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) on locomotor activity and rearing of mice and rats. Psychopharmacology. 102:1990;485-491.
19. 1A receptor antagonist. Behavioural Brain Research. 73:1996;337-353.
20. Galloway M.P. Regulation of dopamine and serotonin synthesis by acute administration of cocaine. Synapse. 6:1990;63-72.
21. Gozlan H., El-Mestikawy S., Pichat L., Glowinski J., Hamon M. Identification of presynaptic serotonin autoreceptors using a new ligand: 3H-PAT. Nature. 305:1983;140-142.
22. Herges S., Taylor D.A. Involvement of serotonin in the modulation of cocaine-induced locomotor activity in the rat. Pharmacology Biochemistry and Behavior. 59:(3):1998;595-611.
23. Herges S., Taylor D.A. Modulatory effect of p-chlorophenylalanine microinjected into the dorsal and median raphe nuclei on cocaine-induced behaviour in the rat. European Journal of Pharmacology. 374:1999a;329-340.
24. Herges S., Taylor D.A. Modulation of cocaine-induced locomotor activity, rears and head bobs by application of WAY 100635 into the dorsal and median raphe nuclei of the rat. Naunyn-Schmiedeberg's Archives of Pharmacology. 360:1999b;129-134.
25. 3 receptors in the nucleus accumbens in the potentiation of cocaine-induced behaviours in the rat. British Journal of Pharmacology. 131:2000;1294-1302.
26. Hillegaart V., Wadenberg M.L., Ahlenius S. Effects of 8-OH-DPAT on motor activity in the rat. Pharmacology Biochemistry and Behavior. 32:1989;797-800.
27. Hjorth S., Magnusson T. The 5-HT 1A receptor agonist, 8-OH-DPAT, preferentially activates cell body 5-HT autoreceptors in rat brain in vivo. Naunyn Schmiedeberg's Archives of Pharmacology. 338:1988;463-471.
28. Hjorth S., Carlsson A., Lindberg P., Sanchez D., Wikstöm H., Arvidsson L.E., et al. 8-Hydroxy-2-(di-n-propylamino)tetralin, 8-OH-DPAT, a potent and selective simplified ergot congener with central 5-HT-receptor stimulating activity. Journal of Neural Transmission. 55:1982;169-188.
29. 1A receptor agonism on antipsychotic drug-induced dopamine release in rat striatum and nucleus accumbens. Brain Research. 858:2000;252-263.
30. Ichikawa J., Kuroki T., Kitchen M.T., Meltzer H.Y. R(+)-8-OH-DPAT, a 5-HT1A receptor agonist, inhibits amphetamine-induced dopamine release in rat striatum and nucleus accumbens. European Journal of Pharmacology. 287:1995;179-184.
31. Kelland M.D., Freeman A.S., Rubin J., Chiodo L.A. Ascending afferent regulation of rat midbrain dopaminergic neurons. Brain Research Bulletin. 31:(5):1993;539-546.
32. Koe B.K. Molecular geometry of inhibitors of the uptake of catecholamines and serotonin in synaptosomal preparations of rat brain. Journal of Pharmacology and Experimental Therapeutics. 199:1976;649-661.
33. A autoreceptors of the dorsal and median raphe nuclei. Journal of Pharmacology and Experimental Therapeutics. 269:(3):1994;1268-1279.
34. 1A receptor agonist, inhibits amphetamine-induced serotonin and dopamine release in rat medial prefrontal cortex. Brain Research. 743:1996;357-361.
35. Lakoski J.M., Cunningham K.A. Cocaine interaction with central monoaminergic systems: electrophysiological approaches. Trends in Pharmacological Sciences. 9:1988;177-180.
36. 2A/C anatgonist, reverse haloperidol-induced catalepsy in rats independently of striatal dopamine release. Psychopharmacology. 131:1997;57-63.
37. Lucki I., Ward H.R., Frazer A. Effect of 1-(m-chlorophenyl)piperazine and 1-(m-trifluoromethylphenyl)piperazine on locomotor activity. Journal of Pharmacology and Experimental Therapeutics. 249:(1):1989;155-164.
38. McCreary A.C., Cunningham K.A. Effects of the 5-HT2C/2B antagonist SB 206553 on hyperactivity induced by cocaine. Neuropsychopharmacology. 20:1999;556-564.
39. 2A receptors attenuates the behavioural effects of cocaine in rats. Journal of Pharmacology and Experimental Therapeutics. 297:2001;357-363.
40. Mittman S.M., Geyer M.A. Effects of 5HT-1A agonists on locomotor and investigatory behaviors in rats differ from those of hallucinogens. Psychopharmacology. 98:1989;321-329.
41. Mogenson G.J., Nielsen M. A study of the contribution of hippocampal-accumbens-subpallidal projections to locomotor activity. Behavioural and Neural Biology. 42:1984;38-51.
42. 1A-receptor antagonist WAY 100635 blocks behavioural stimulating effects of cocaine but not ventral striatal dopamine release. Behavioural Brain Research. 134:2002;337-346.
43. 1A-receptor antagonism blocks behavioural but potentiates serotonergic activation. Synapse. 45:2002;67-77.
44. 1A receptor antagonist (S)-UH-301 decreases dopamine release in the rat nucleus accumbens and striatum. Journal of Neural Transmission. 103:1996;541-554.
45. Parsons L.H., Justice J.B. Perfusate serotonin increases extracellular dopamine in the nucleus accumbens as measured by in vivo microdialysis. Brain Research. 606:1993;195-199.
46. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates. 1986;Academic Press, New York.
47. Pitts D.K., Marwah J. Electrophysiological effects of cocaine on central monoaminergic neurons. European Journal of Pharmacology. 131:1986;95-98.
48. Pradhan S.N., Battacharyya A.K., Pradhan S. Serotonergic manipulation of the behavioral effects of cocaine in rats. Communications in Psychopharmacology. 2:1978;481-486.
49. 1A receptors attenuates the locomotor, but not the discriminative, effects of amphetamine and cocaine in rats. Behavioural Pharmacology. 8:1997;699-706.
50. Reith M.E. 5-HT3 receptor antagonists attenuate cocaine-induced locomotion in mice. European Journal of Pharmacology. 186:1990;327-330.
51. Rex A., Marsden C.A., Fink H. Effect of diazepam on cortical 5-HT release and behaviour in the guinea-pig on exposure to the elevated plus maze. Psychopharmacology. 110:1993;490-496.
52. 1B serotonin receptors in adult rat brain. Journal of Comparative Neurology. 417:2000;181-194.
53. Ritz M.C., Cone E.J., Kuhar M.J. Cocaine inhibition of ligand binding at dopamine, norepinephrine and serotonin transporters: a structure-activity study. Life Science. 46:1990;635-645.
54. Rocha B.A., Fumagalli F., Gainetdinov R.R., Jones S.R., Ator R., Giros B., et al. Cocaine self-administration in dopamine-transporter knockout mice. Nature Neuroscience. 1:1998;132-137.
55. Rutter J.J., Gundlah C., Auerbach S.B. Systemic uptake inhibition decreases serotonin release via somatodendritic autoreceptor activation. Synapse. 20:1995;225-233.
56. Scheel-Krüger J., Braestrup C., Nielson M., Golembiowska K., Moglinicka E. Cocaine: discussion on the role of dopamine in the biochemical mechanism of action. Ellinwood E.H., Kilbey M.M. Cocaine and Other Stimulants. 1977;373-407 Plenum Press, New York.
57. Sinton C.M., Fallon S.L. Electrophysiological evidence for a functional differentiation between subtypes of the 5-HT1 receptor. European Journal of Pharmacology. 157:1988;173-181.
58. Sora I., Hall F.S., Andrews A.M., Itokawa M., Li X.F., Wei H.B., et al. Molecular mechanisms of cocaine reward: combined dopamine and serotonin transporter knockouts eliminate cocaine place preference. Proceedings of the National Academy of Science USA. 98:2001;5300-5305.
59. 1B agonists: a comparative study with dorsal raphe neurons. Neuropharmacology. 27:1988;707-715.
60. Svingos A.L., Hitzemann R. 5-HT3 receptor antagonists block cocaine-induced locomotion via a PCPA-sensitive mechanism. Pharmacology Biochemistry and Behaviour. 43:1992;871-879.
61. Tricklebank M.D., Forler C., Fozard J.R. The involvement of subtypes of the 5-HT1 receptor and of catecholaminergic systems in the behavioural response to 8-hydroxy-2-(di-n-propylamino)tetralin in the rat. European Journal of Pharmacology. 106:1985;271-282.
62. Tricklebank M.D., Middlemiss D.N., Neill J. Pharmacological analysis of the behavioural and thermoregulatory effects of the putative 5-HT1 receptor agonist, RU 24969, in the rat. Neuropharmacology. 25:(8):1986;877-886.
63. Walsh S.L., Cunningham K.A. Serotonergic mechanisms involved in the discriminative stimulus, reinforcing and subjective effects of cocaine. Psychopharmacology. 130:1997;41-58.
64. Wise R.A. Drug-activation of brain reward pathways. Drug and Alcohol Dependence. 51:1998;13-22.
65. Wolf W.A., Youdim M.B., Kuhn D.M. Does brain 5-HIAA indicate serotonin release or monoamine oxidase activity? European Journal of Pharmacology. 109:1985;381-387.
66. Yang X.M., Gorman A.L., Dunn A.J., Goeders N.E. Anxiogenic effects of acute and chronic cocaine administration: neurochemical and behavioral studies. Pharmacology Biochemistry and Behavior. 41:1992;643-650.